Vergoeding 2015-2019 voor ATC-subgroep N03AX : Overige anti-epileptica
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| N03AX03 Sultiam (Ospolot ®) | 1 | 155 | . | . | . |
| N03AX09 Lamotrigine (Lamictal ®) | 2.572.100 | 2.558.600 | 2.435.600 | 2.692.300 | 2.750.300 |
| N03AX10 Felbamaat (Taloxa ®) | 134.530 | 128.000 | 132.360 | 118.920 | 118.160 |
| N03AX11 Topiramaat (Topamax ®) | 998.200 | 972.640 | 905.130 | 1.107.200 | 1.296.000 |
| N03AX12 Gabapentine (Neurontin ®) | 1.514.300 | 1.478.400 | 1.388.500 | 1.584.900 | 1.870.300 |
| N03AX14 Levetiracetam (Keppra ®) | 6.031.800 | 5.754.900 | 4.737.100 | 5.208.700 | 5.176.600 |
| N03AX15 Zonisamide (Zonegran ®) | 491.640 | 506.320 | 439.040 | 383.930 | 367.280 |
| N03AX16 Pregabaline (Lyrica ®) | 43.696.200 | 31.931.900 | 23.810.300 | 9.321.000 | 8.454.400 |
| N03AX17 Stiripentol (Diacomit ®) | 417.710 | 397.340 | 450.630 | 451.630 | 421.600 |
| N03AX18 Lacosamide (Vimpat ®) | 2.533.400 | 3.006.800 | 3.569.500 | 4.197.800 | 4.908.900 |
| N03AX21 Retigabine | 24.750 | 21.523 | 1.488 | . | . |
| N03AX22 Perampanel (Fycompa ®) | 386.940 | 527.780 | 548.030 | 593.370 | 674.360 |
| N03AX23 Brivaracetam (Briviact ®) | . | 48.261 | 436.970 | 948.830 | 1.654.400 |
| Totaal | 58.801.571 | 47.332.619 | 38.854.648 | 26.608.580 | 27.692.300 |